CRGC News Broadcast
NB-2019-002
February 22, 2019
2019 SEER Reliability Study

The 2019 Extent of Disease (EOD)/Summary Stage/Site-Specific Data Items (SSDI) Reliability Study aims to:
  • Assess how well registrars can assign EOD Primary Tumor, EOD Regional Nodes, EOD Mets, SS2018 (Summary Stage 2018), Grade, SSDI, Regional Nodes Positive and Tumor Size using information available in the medical record
  • Provide information on training needs
  • Provide a baseline to evaluate the effectiveness of training materials that are developed
This study will take place from 5 am Pacific (8 am Eastern), March 1, 2019 to 9 pm Pacific, April 15, 2019. Participants must have access to the SEER reliability studies site https://reliability.seer.cancer.gov during this period.

Completion of the study will require the review and coding of EOD 2018 Data Items (Primary Tumor, Regional Nodes, Mets), SS2018, Grade, SSDIs (schema specific), Regional Nodes Positive and Tumor Size. Registrars will complete 1 randomly selected set of cases (10 cases) with an option to complete as many as 4 additional sets (up to 40 additional cases). In addition to Continuing Education credits, participants in this activity will have an opportunity to view the preferred answers as given by an expert panel. You will be notified when the study results become available online. 
  • NCRA has approved 10 CEUs for completion of one set (10 cases). No partial credit will be given.
Note that since the objectives of this study are to determine training needs and not designed as a test for accuracy of EOD code assignment, individual study results will remain confidential and not released to NCI SEER staff or registry managers. Study results will be de-identified before analysis.

All participants will be using the SEER Reliability software. If you have participated in a previous reliability study (2014 or later), use your same login. If you have not participated in a previous reliability study, you will need to create an account. To create a new account please follow the Create an Account link on the sign-in page https://reliability.seer.cancer.gov.

Please email reliability@imsweb.com for technical questions and Jennifer Ruhl   ruhlj@MAIL.NIH.GOV for study related questions.

Your participation is important for helping us assess the training needs for EOD 2018, Summary Stage 2018, Grade and SSDIs and therefore, while participation is voluntary, we strongly encourage you to participate in this study.

Thank you, 

Jennifer Ruhl, MSHCA, RHIT, CCS, CTR
Public Health Analyst, NCI SEER
If you have questions or concerns regarding any of the content of this CRGC News Broadcast please contact me .   

Mignon Dryden, CTR
Director, E-Reporting
Cancer Registry of Greater California